Schauer, Nathan J. http://orcid.org/0000-0002-3004-4923
Liu, Xiaoxi
Magin, Robert S.
Doherty, Laura M.
Chan, Wai Cheung http://orcid.org/0000-0001-8413-5401
Ficarro, Scott B.
Hu, Wanyi
Roberts, Rebekka M.
Iacob, Roxana E. http://orcid.org/0000-0001-6106-4698
Stolte, Björn
Giacomelli, Andrew O. http://orcid.org/0000-0003-2109-0458
Perera, Sumner
McKay, Kyle
Boswell, Sarah A. http://orcid.org/0000-0002-3118-3378
Weisberg, Ellen L.
Ray, Arghya
Chauhan, Dharminder
Dhe-Paganon, Sirano
Anderson, Ken C.
Griffin, James D.
Li, Jianing http://orcid.org/0000-0002-0143-8894
Hahn, William C. http://orcid.org/0000-0003-2840-9791
Sorger, Peter K. http://orcid.org/0000-0002-3364-1838
Engen, John R. http://orcid.org/0000-0002-6918-9476
Stegmaier, Kimberly http://orcid.org/0000-0003-0218-7895
Marto, Jarrod A. http://orcid.org/0000-0003-2086-1134
Buhrlage, Sara J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
St. Baldrick's Foundation
Article History
Received: 14 January 2019
Accepted: 25 February 2020
First Online: 24 March 2020
Competing interests
: K. Stegmaier participates in the DFCI/Novartis Drug Discovery Program, which included grant support and consulting and has consulted for Rigel Pharmaceuticals on topics unrelated to this manuscript. J.A.M. serves on the SAB of 908 Devices and receives sponsored research support from Vertex and AstraZeneca. The authors declare no other potential conflicts of interest.